Disruptor 50: Ginkgo Bioworks CEO Jason Kelly on fighting Covid-19

Ginkgo Bioworks is on the CNBC Disruptor 50 list for the fourth time. The company has had to pivot during the pandemic, focusing its efforts on Covid-19 relief and partnering with companies like Roche and Moderna. Jason Kelly, Ginkgo Bioworks CEO, joins "Squawk Box" to discuss.
Thu, Jun 18 20207:01 AM EDT